首页> Scientific reports> Application of Targeted Mass Spectrometry for the Quantification of Sirtuins in the Central Nervous System.

Application of Targeted Mass Spectrometry for the Quantification of Sirtuins in the Central Nervous System.

导出 LinkOut

翻译打印收藏纠错

第一作者： T,Jayasena

第一单位： Centre for Healthy Brain Ageing (CHeBA), School of Psychiatry, University of New South Wales, Sydney, Australia.

作者： T,Jayasena ^[1] ; A,Poljak ^[2] ; N,Braidy ^[1] ; L,Zhong ^[3] ; B,Rowlands ^[4] ; J,Muenchhoff ^[1] ; R,Grant ^[5] ; G,Smythe ^[4] ; C,Teo ^[6] ; M,Raftery ^[3] ; P,Sachdev ^[7]

作者单位： Centre for Healthy Brain Ageing (CHeBA), School of Psychiatry, University of New South Wales, Sydney, Australia. ^[1] Centre for Healthy Brain Ageing (CHeBA), School of Psychiatry, University of New South Wales, Sydney, Australia.;Bioanalytical Mass Spectrometry Facility, Mark Wainwright Analytical Centre, University of New South Wales, Sydney, Australia.;School of Medical Sciences, University of New South Wales, Sydney, Australia. ^[2] Bioanalytical Mass Spectrometry Facility, Mark Wainwright Analytical Centre, University of New South Wales, Sydney, Australia. ^[3] School of Medical Sciences, University of New South Wales, Sydney, Australia. ^[4] School of Medical Sciences, University of New South Wales, Sydney, Australia.;Sydney Medical School, University of Sydney, Sydney, Australia. ^[5] Minimally Invasive Cancer Centre, Prince of Wales Hospital, Sydney, Australia. ^[6] Centre for Healthy Brain Ageing (CHeBA), School of Psychiatry, University of New South Wales, Sydney, Australia.;Neuropsychiatric Institute, the Prince of Wales Hospital, Sydney, Australia. ^[7]